1. A ¹²⁵I-protein A-binding assay detecting antibodies to cell surface antigens

   • R. Fäldt
   • J. Ankerst

   Original Articles Pages: 69 - 77

2. Thymosin α₁ restores NK-cell activity and prevents tumor progression in mice immunosuppressed by cytostatics or X-rays

   • Yukio Umeda
   • Atsuko Sakamoto
   • Yasuo Yagi

   Original Articles Pages: 78 - 83

3. Immunotherapy of lewis lung carcinoma with hydrosoluble peptidoglycan monomer (PGM)

   • G. Sava
   • T. Giraldi
   • I. Hršak

   Original Articles Pages: 84 - 86

4. Characterization of tumor-associated lymphocytes in a series of mouse mammary tumor lines with differing biological properties

   • Angelyn M. Rios
   • Fred R. Miller
   • Gloria H. Heppner

   Original Articles Pages: 87 - 91

5. The role of humoral immunity and the contribution of the F₁ anti-parental effect in the rejection of a moloney leukemia virus-induced lymphoma graft

   • Birgitta Åsjö
   • Eva Klein
   • George Klein

   Original Articles Pages: 92 - 95

6. In vivo studies of spleen lymphoid cells implicated in antitumor immunity in hamsters

   • Hedi Haddada
   • Ch. de VauxSaint Cyr
   • A. Duthu

   Original Articles Pages: 96 - 100

7. Increase in the effectiveness of melphalan therapy with progression of MOPC-315 plasmacytoma tumor growth

   • Shlomo Ben-Efraim
   • Robert C. Bocian
   • Sheldon Dray

   Original Articles Pages: 101 - 107

8. Immunomodulating activity of thymosin fraction 5 and thymosin α₁ in immunosuppressed mice

   • Yumiko Ohta
   • Kazuo Sueki
   • Yasuo Yagi

   Original Articles Pages: 108 - 113

9. Serial immune testing in surgically resected lung cancer patients

   • Donald P. Braun
   • Sharon Nisius
   • Jules E. Harris

   Original Articles Pages: 114 - 120

10. Restoration by levamisole of immune responses suppressed in tumor-bearing mice

    • Morio Shiraishi
    • Kunisuke Himeno
    • Kikuo Nomoto

    Original Articles Pages: 121 - 125

11. Control of the carcinogenic potential of ^99mTechnetium by the immunologic hormone lymphotoxin

    • Janet H. Ransom
    • Charles H. Evans
    • Joseph A. DiPaolo

    Original Articles Pages: 126 - 130

12. Antibody response to a solubilized tumor-associated membrane antigen (TAMA) from the murine lewis lung tumor

    • John R. McKolanis
    • Robert W. Veltri

    Original Articles Pages: 131 - 137

13. Circulating immune complexes in malignant diseases increased detection rate by simultaneous use of three assay methods

    • F. Krapf
    • D. Renger
    • H. Deicher

    Original Articles Pages: 138 - 143

14. The treatment of cancer patients with human lymphoblastoid interferon

    • James A. Knost
    • Stephen A. Sherwin
    • Robert K. Oldham

    Original Articles Pages: 144 - 148

15. Cellular suppression of murine ADCC and NK activities induced by Corynebacterium parvum

    • Vita K. Milisauskas
    • Gustavo Cudkowicz
    • Ichiro Nakamura

    Original Articles Pages: 149 - 154

16. Depressed lectin-dependent cell-mediated cytotoxicity against adherent HEP-2 cells in patients with carcinoma of the uterine cervix

    • András Perl
    • Rhenso Gonzalez-Cabello
    • Péter Gergely

    Original Articles Pages: 155 - 158

17. Effect of dichloromethylene diphosphonate (Cl₂MDP) on immune function in breast cancer patients with bone metastases

    • Ritva Markkula
    • Heikki Repo
    • Inkeri Elomaa

    Short Communication Pages: 159 - 161

18. Potentiation of the defective monocyte chemotaxis in Hodgkin's disease by in vitro tuftsin treatment

    • K. Lukács
    • E. Berényi
    • M. Szekerke

    Short Communication Pages: 162 - 163

19. Meeting announcements

    Announcement Pages: 164 - 164